Canada markets closed

Tilray, Inc. (TLRY.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
19.18-0.87 (-4.34%)
At close: 3:59PM EDT
Sign in to post a message.
  • C
    Cale
    Because of yesterday‘s financial disclosures this changes everything. Rather than looking nervously on a daily basis whether the stock will go up or down, I speak for myself and I think a few others when I say that we can just chill, be at peace, and check up on the stock once a week or so. This is now more like a blue chip healthcare, or pharma, or beverage stock ( take your pick or select all of the above) than anything else. The financials have totally validated the company’s ability to grow , as well as given thumbs up and Carte Blanche the talent and strategic direction of the capable management team. Again yesterday changed everything. 
  • E
    Elevate
    People selling are not well informed; Tilray’s future is EPIC 🌎 I fully expect to see the share price near $50. this year after a few catalysts occur like: Outstanding earnings report in October; progress on legalization in both Europe & US; partnerships & acquisitions; new product offerings and research; SweetWater Music Festival; Simon doing his magic and becoming the “Face” of cannabis with regular media appearances; increasing momentum and positive sentiment for cannabis and it’s medicinal properties 💎
  • L
    Lucifer Morningstar
    Huge buy opening bell over 3 million shares!!!
  • E
    Elon
    After watching the analyst video and Simon saying 4B in sales by 2024 and breaking it down, explaining exactly how he is going to get those numbers. There could be way more upside based on what he acquires.

    He said if nothing happens and he doesn’t acquire Anything and not acquiring any USA MSO’s, no legalization etc, just the businesses TLRY currently owns will be 2 billion in sales alone by 2024.

    Either way I like those numbers
  • R
    Radeon
    This stock went up almost 30% on good earnings. Imagine what federal legalization will do.
  • S
    Steve
    Bank of America has a Buy rating and $21.50 price target for Tilray.
  • J
    Jonathan
    25% increase yesterday and bashers getting excited over -1.00% on open today.
  • M
    Matt
    Bottom Line: Tilray will be the #1, #2 or #3 company, in one of the fastest growing industries over the next 3-5 years. Even the bashers understand those 2 facts. Just relax and enjoy this ride. If you're daytrading TLRY, it's a different ballgame, but the long team will easily win over the next 3-5 years.
  • J
    Joe
    I learned two things today: 1. I will not trust Yahoo headlines; Bloomberg is more accurate/fair. 2. My faith in Simon is now solidified. He knows what he is doing! We know that federal legalization is important to institutional investors; however, 80% of TLRY investors are retail right now. Simon know this ratio needs to even out. I've seen awful reporting days for TLRY. This is NOT one of them. Great job TLRY!
  • r
    robby
    Why would anybody sell the stock now since it proved it to be self profitable and only expanding and getting larger from here this is a no-brainer stock!!!
  • J
    Joe Dirt
    10HRS AGO INTERVIEW.. CEO Irwin Simon said he has ambitious plans to maintain the company's momentum across its entire portfolio that includes hemp foods, craft beer, and a German pharmaceutical distribution business and generate US$4 billion in sales by the end of its fiscal 2024. He also said "We have to do 60 mph in a 50 zone. We can't be just driving a car and do the speed limit," he told BNN Bloomberg in a phone interview" LOOKS DANG GOOD DUDES!
  • W
    WebWorld
    As I,ve stated many times in the past and was ridiculed for it, Simon has a black belt in CEO .
  • N
    Nancy
    3,000 shares at 6.71 … have been way down at times; bought it when it was aphria. Always believed in the biz and the Mgmt. Long term hold; will probably end up being inherited by my kids in 20 yrs
  • C
    Captainkgood
    It’s a global market and this is the biggest pot company in the world. There will be multiple winners, and this will be one of them. Long and strong.
  • L
    Lucifer Morningstar
    Good morning
    Over a million shares covered last night in post trading, 1.7 million shares covered in pre trading!!! We finally got a proper short squeeze happening!!! Lol
    Fintel is using a new formula for its calculations. Something to be explained at a latter date. For now let’s enjoy the ride!!!
    Cheers!!!
  • d
    doug
    I am very disappointed that Tilray stockholders don't care enough to even vote. While I understand that not voting is the same as voting no, even a retail investor should understand the importance of having a quorum so that the meeting does not have to be postponed at additional expense.
  • m
    murch
    I had 500 shares. Yesterday, I bought 10 calls when it was trading at 12.70. Thank you shorts for the great discount! And no, I didn't sell today. There is a lot more fuel in the tank for this baby.
  • N
    Nicholas
    If you do not know the difference between Authorized and Issued shares... you should probably stop posting.. liquidate and go buy some mutual funds. Individual stocks are not were you should be.
  • c
    craig
    its hilarious how the media announces the ER as negative - as their headline. stating Tilray Misses Revenue Estimates. ummmm...they missed by only 4M. Tilray actually made a profit of over 30M, had an above expected + 12M EBITDA. and all this with a one time 19.9M adjustment charge. these are great #'s for Tilray. Well done!
  • A
    AL
    On a conference all with analysts, Simon set out a goal of achieving $4 billion of revenue by 2024, which assumes full legalization of cannabis in the U.S., along with organic growth, acquisitions and partnerships.

    "Beyond what we have achieved over the last six months, our perseverance during COVID crisis itself lends further validation to the fact that this team knows how to pivot, execute and get results," he said, according to a FactSet transcript. "Consider at the highest level, we lost well over $100 million in revenue as a result of retail store closures and COVID general impact. And yet, we immediately implemented cost saving measures, ultimately helping us build EBITDA to more than $40 million in 2021."

    Cantor's Zuanic lauded the "ambitious vision" offered on the call, although he said the stock action may have more to do with a short squeeze. Tilray has become one of the "meme" stocks tracked closely by investors on Reddit forums. Still, the analyst reiterated his overweight rating on the stock, the equivalent of buy, and a $19 price target that's 19% above its current price.